华森制药：关于公司全资子公司通过高新技术企业认定的公告

Group 1 - The core announcement is that Huason Pharmaceutical's subsidiary, Chongqing Huason Inno Biotechnology Co., Ltd., has been recognized as a national high-tech enterprise for the year 2025, with a certificate number GR202551102448 and a validity period of three years [2] Group 2 - The recognition was issued by the National High-tech Enterprise Recognition Management Work Leading Group, indicating the company's compliance with national standards for high-tech enterprises [2] - This recognition may enhance the company's reputation and potentially lead to increased investment opportunities and funding [2] - The announcement reflects the company's ongoing commitment to innovation and development in the biotechnology sector [2]